Figure 2.

Lung high-resolution CT in Patient 1 and cutaneous findings in Patient 2, pre- and post-treatment with tofacitinib. (A) Lung view HRCT of Patient 1 showing bilateral lower lobe reticular nodular infiltrates and ground glass opacities 17 months prior to starting tofacitinib therapy. (B) Lung view HRCT of Patient 1 showing near resolution of infiltrates and ground glass opacities 16 months after tofacitinib therapy. (C) Palmar surface of right hand with erythema and ulcerations prior to tofacitinib therapy in Patient 2. (D) Palmar surface of right hand with complete resolution of erythema and ulceration 12 months after tofacitinib therapy in Patient 2.